These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23250333)

  • 1. Pretransplantation pharmacokinetic curves of tacrolimus in HIV-infected patients on ritonavir-containing cART: a pilot study.
    van Maarseveen EM; Crommelin HA; Mudrikova T; van den Broek MP; van Zuilen AD
    Transplantation; 2013 Jan; 95(2):397-402. PubMed ID: 23250333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients.
    Jain AB; Venkataramanan R; Eghtesad B; Marcos A; Ragni M; Shapiro R; Rafail AB; Fung JJ
    Liver Transpl; 2003 Sep; 9(9):954-60. PubMed ID: 12942457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
    Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipient.
    Barau C; Blouin P; Creput C; Taburet AM; Durrbach A; Furlan V
    Fundam Clin Pharmacol; 2009 Aug; 23(4):423-5. PubMed ID: 19709321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.
    Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE
    Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients.
    Solas C; Simon N; Drogoul MP; Quaranta S; Frixon-Marin V; Bourgarel-Rey V; Brunet C; Gastaut JA; Durand A; Lacarelle B; Poizot-Martin I
    Br J Clin Pharmacol; 2007 Sep; 64(3):353-62. PubMed ID: 17517050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
    Kuypers DR; Vanrenterghem Y
    Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients.
    Pea F; Tavio M; Pavan F; Londero A; Bresadola V; Adani GL; Furlanut M; Viale P
    Antivir Ther; 2008; 13(5):739-42. PubMed ID: 18771060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-drug interaction in a kidney transplant recipient receiving HIV salvage therapy and tacrolimus.
    Mertz D; Battegay M; Marzolini C; Mayr M
    Am J Kidney Dis; 2009 Jul; 54(1):e1-4. PubMed ID: 19346040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients.
    Vogel M; Voigt E; Michaelis HC; Sudhop T; Wolff M; Türler A; Sauerbruch T; Rockstroh JK; Spengler U
    Liver Transpl; 2004 Jul; 10(7):939-44. PubMed ID: 15237382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
    Stock PG; Roland ME; Carlson L; Freise CE; Roberts JP; Hirose R; Terrault NA; Frassetto LA; Palefsky JM; Tomlanovich SJ; Ascher NL
    Transplantation; 2003 Jul; 76(2):370-5. PubMed ID: 12883195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults.
    Ribera E; Lopez RM; Diaz M; Pou L; Ruiz L; Falcó V; Crespo M; Azuaje C; Ruiz I; Ocaña I; Clotet B; Pahissa A
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4256-62. PubMed ID: 15504850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
    Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
    J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients.
    Scholten EM; Cremers SC; Schoemaker RC; Rowshani AT; van Kan EJ; den Hartigh J; Paul LC; de Fijter JW
    Kidney Int; 2005 Jun; 67(6):2440-7. PubMed ID: 15882290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal transplantation in HIV-infected patients in Spain].
    Mazuecos A; Pascual J; Gómez E; Sola E; Cofán F; López F; Puig-Hooper CE; Baltar JM; González-Molina M; Oppenheimer F; Marcén R; Rivero M
    Nefrologia; 2006; 26(1):113-20. PubMed ID: 16649432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Limited Sampling Strategies for the Estimation of Tacrolimus Area Under the Curve in Adult Kidney Transplant Recipients According to the Posttransplantation Time.
    Aouam K; Chadli Z; Hammouda M; Fredj NB; Aloui S; May ME; Boughattas N; Skhiri H; Chaabane A
    Ther Drug Monit; 2015 Aug; 37(4):524-30. PubMed ID: 25627405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of kidney transplantation in HIV-infected recipients.
    van Maarseveen EM; van Zuilen AD; Mudrikova T
    N Engl J Med; 2011 Feb; 364(7):683; author reply 684. PubMed ID: 21323551
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation.
    Chakkera HA; Chang YH; Bodner JK; Behmen S; Heilman RL; Reddy KS; Mulligan DC; Moss AA; Khamash H; Katariya N; Hewitt WR; Pitta TL; Frassetto LA
    Transplant Proc; 2013; 45(1):137-41. PubMed ID: 23375287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin inhibitor dose-finding before kidney transplantation in HIV patients.
    Pulzer A; Seybold U; Schönermarck U; Stangl M; Habicht A; Bogner JR; Franke J; Fischereder M
    Transpl Int; 2013 Mar; 26(3):254-8. PubMed ID: 23227980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.